| Literature DB >> 21569328 |
Abdisalan M Noor1, Maoulid B Mohamed, Cleopatra K Mugyenyi, Mouna A Osman, Hawa H Guessod, Caroline W Kabaria, Ifrah A Ahmed, Mary Nyonda, Jackie Cook, Christopher J Drakeley, Margaret J Mackinnon, Robert W Snow.
Abstract
BACKGROUND: Countries aiming for malaria elimination require a detailed understanding of the current intensity of malaria transmission within their national borders. National household sample surveys are now being used to define infection prevalence but these are less efficient in areas of exceptionally low endemicity. Here we present the results of a national malaria indicator survey in the Republic of Djibouti, the first in sub-Saharan Africa to combine parasitological and serological markers of malaria, to evaluate the extent of transmission in the country and explore the potential for elimination.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21569328 PMCID: PMC3114736 DOI: 10.1186/1471-2334-11-121
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Figure 1Map of the Republic of Djibouti showing inland water, roads, railway, administrative regions and major settlements geo-coded in Google Earth and obtained from DEPHA [64], showing location of clusters with persons indentified as sero-positive for [33].
Summary by age of the prevalence of P. falciparum antibody exposures and/or infections, period prevalence of fever two-weeks from the survey day and fever on the survey day and use of insecticide treated nets (ITN) the night prior to survey shown as cluster-adjusted and weighted percentages (95%CI) [n/N].
| Fever prevalence in the two weeks prior to survey | Fever prevalence on the day of survey | Use of ITN | ||||
|---|---|---|---|---|---|---|
| Totals | 9.9 | 0.50 | 10.5 | 5.2 | 1.9 | 14.5 |
| < 5 years | 6.9 | 0.23 | 7.1 | 18.5 | 4.3 | 15.8 |
| 5 - 9 years | 4.9 | 0.61 | 5.7 | 6.6 | 3.8 | 17.1 |
| 10 - 14 years | 5.0 | 0.34 | 5.6 | 1.9 | 0.8 | 12.6 |
| 15 - 34 years | 11.4 | 0.49 | 11.9 | 2.5 | 0.9 | 12.5 |
| 35 - 49 years | 14.0 | 0.64 | 14.7 | 3.4 | 1.6 | 16.7 |
| 50 + years | 14.2 | 0.67 | 15.0 | 2.2 | 0.5 | 13.6 |
| χ2 for trend | 68.27, | 3.29, | 67.04, | 268.71, | 50.06, | 14.23, |
For infection prevalence the denominator is all those individuals who gave a finger prick blood sample (n = 7151). For combined infection and antibody prevalence, fever prevalence and ITN use the denominator is the total of samples that had concordant optical density values of P. falciparum antibody AMA-1 and MSP-119 antibody exposure (n = 4769).
a Seven individuals had missing age data
b 14 individuals had missing age data
c An individual was regarded as a positive case if he/she showed presence of P. falciparum infection and/or antibodies in the blood sample. Six of the P. falciparum RDT/PCR positive were also positive for antibodies. Three individuals who were RDT positive and PCR confirmed were not successfully assayed. Overall, however, infected individuals showed higher titre responses (mean/median = 196.2/98.8) compared to uninfected individuals (mean/median titres = 161.3/92.2).
Figure 2Age specific sero-prevalence plot of [37]. The vertical axis shows the proportion of sero-positive individuals in each age group, the horizontal axis shows the midpoint age. Red triangles represent observed prevalence and blue fitted line is predicted age prevalence curve. λ = 0.0134 (95% CI, 0.010 - 0.018) and ρ = 0.0799 (95% CI, 0.0532 - 0.1200).
Predictors of combined P. falciparum antibody and infection prevalence shown as cluster-adjusted and weighted percentages (95%CI) [n/N]
| χ2 , p-value | ||
|---|---|---|
| 12.8 (7.7 - 18.0) [188/1291] vs 9.9 (7.1 - 12.6) [362/3478] | 7.89, | |
| Ali Sabieh | 11.7 (4.1 - 19.3) [57/454] | |
| Arta | 10.5 (6.2 - 14.9) [25/222] | |
| Dikhil | 14.1 (7.0 - 21.3) [109/711] | |
| Djibouti Ville | 8.1 (4.8 - 11.4) [172/2032] | |
| Obock | 11.3 (5.6 - 17.1) [68/595] | |
| Tadjourah | 14.0 (6.0 - 21.9) [119/755] | 33.98 |
| 12.2 (6.5 - 17.8) [100/740] vs 10.30 (7.9 - 12.6 [450/4029] | 2.31, | |
| 9.0 (4.1 - 14.0) [26/254] vs 10.6 (8.2 - 13.1) [524/4515] | 0.63, | |
| 15.5 (6.3 - 24.7) [14/91] vs 10.5 (8.1 - 12.9) [536/4678] | 2.35, | |
| 12.0 (8.4 - 15.7) [343/2727] vs 9.7 (5.8 - 11.6) [207/2042] | 13.83, | |
| 11.5 (8.2 - 14.9) [362/2987] vs 9.0 (5.7 - 12.3) [188/1782] | 7.44, | |
| 10.2 (6.7 - 13.7) [274/2456] vs 11.0 (7.6 - 14.3) [276/2313] | 0.74, | |
| 9.5 (6.7 - 12.4) [276/2466] vs 12.6 (8.3 - 17.1) [274/2303] | 0.01, | |
| 10.5 (7.2 - 13.9) [60/403] vs 10.6 (7.0 - 14.1) [490/4366] | 3.03, | |
| 15.0 (9.0 - 21.0) [171/1063] vs 6.3 (3.4 - 9.2) [64/973] | 41.83, |
Multivariate regression results of the predictors of combined P. falciparum antibody exposure and/or infection prevalence shown as cluster-adjusted and weighted Odds Ratio (95%CI) and P-value of the start full model and final reduced model.
| Start Full model | Final reduced model | |||
|---|---|---|---|---|
| 1.4 (1.2 - 1.6) | 0.0001 | 1.4 (1.2 - 1.6) | 0.0001 | |
| 0.9 (0.4 - 1.7) | 0.660 | |||
| 1.0 (0.6 - 1.6) | 0.996 | |||
| 0.9 (0.6 - 1.5) | 0.792 | |||
| 1.4 (0.8 - 2.4) | 0.214 | |||
| 0.9 (0.5 - 1.5) | 0.631 | |||
| 0.8 (0.5 - 1.3) | 0.406 | |||
| 1.1 (0.7 - 1.8) | 0.361 | |||
| 0.7 (0.6 - 0.8) | 0.0001 | 0.8 (0.7 - 0.9) | 0.0001 | |
At each stage of the regression a predictor variable (one with the highest non-significant P-value) was removed from the model in a backwards step-wise approach until all variables in the model had a P-value of less than 0.05.
a The age grouping shown in Table 1 was used during the regression. 14 individuals had missing age data.
b Individuals were classified into the wealth quintile of their resident household.
c Median distances were used
Figure 3The location of clusters that are . Significance of clustering was analysed using the Getis-Ord G-statistic [38]. Positive Z-scores with significant G-statistic indicated hot spots while negative Z-scores indicated cold spots. The G-statistic was computed using ArcGIS 9.3 Spatial Statistics toolbox (ESRI Inc. USA). 33/34 of the cold spots were in Djibouti Ville while all hot spots were in Dikhil region.